Last
Update:
August 25, 2017
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
Nevirapine induced mitochondrial dysfunction in HepG2 cells.
Paemanee A, Sornjai W, Kittisenachai S, et al
Sci Rep .
2017 Aug 23;7(1):9194.
Abstract
Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer
cells. Jensen K, Bikas AD,
Patel A, et al
. 2017 Jan 30.
Abstract
Differences in nevirapine biotransformation as a factor for its sex-dependent
dimorphic profile of adverse drug reactions.
Marinho AT, Rodrigues PM, Caixas U, et al
J . 2014
Feb;69(2):476-82.
Abstract
Residual viremia in patients on antiretroviral therapy incorporating nevirapine
is not associated with the gag-specific cellular immune response.
McIlroy D, Allavena C, Rodallec A, et al
. 2013 Sep 23.
Abstract
Differences in nevirapine biotransformation as a factor for its sex-dependent
dimorphic profile of adverse drug reactions.
Marinho AT, Rodrigues PM, Caixas U, et al
.
2013 Sep 19
Abstract
FULL-TEXT ARTICLE
DRESS Syndrome due
to Nevirapine Treated with Methylprednisolone.
Pott Junior H, Gosuen GC, Gales AC.
Case Rep Med . 2013;2013:269501
Paper
Adverse events associated with nevirapine and efavirenz-based
first-line antiretroviral therapy: a systematic review and meta-analysis.
Shubber Z, Calmy A, Andrieux-Meyer I, et al
. 2013 Jan 22. [
Abstract
Long-term therapy with nevirapine and tropism.
Moling O, Andreis S, Bressan S,et
al
. 2012 Nov
11;15(6):18157
Abstract
Pharmacogenetics of Toxicity, Plasma Trough Concentration and Treatment Outcome
with Nevirapine-Containing Regimen in Anti-Retroviral-Naïve HIV-Infected Adults:
an Exploratory Study of the TRIANON ANRS 081 Trial.
Gozalo C, Gérard L, Loiseau P, et al
.
2011 Aug 9.
Abstract
Nevirapine-associated toxicity in clinical practice in Buenos Aires, Argentina.
Bottaro EG, Huberman MJ, Iannella Mdel C,
et al
2010 Sep-Oct;9(5):306-12.
Abstract
Amino Acid Adduct Formation by the Nevirapine Metabolite,
12-Hydroxynevirapine
A Possible Factor in Nevirapine Toxicity.
Antunes AM, Godinho AL, Martins IL,
et al
.
2010 Apr 14.
Abstract
Risk factors for treatment-limiting toxicities in
patients starting nevirapine-containing
antiretroviral therapy. Kesselring AM, Wit FW, Sabin CA,
et al
.
2009 May 29.
Abstract
Nevirapine Toxicity in Non-HIV Cancer Patients.
Landriscina M, Fabiano A, Lombardi V, et al
Abstract
Nevirapine toxicity.
Taiwo BO.
Int J STD AIDS. 2006 Jun;17(6):364-70.
Abstract
Incidence and risk factors of skin rashes and
hepatotoxicity in HIV-infected patients receiving
nevirapine-containing combination antiretroviral therapy in Taiwan.
Tseng YT, Yang CJ, Chang SY, et al
Int J Infect Dis .
2014 Oct 10
Abstract
FULL-TEXT ARTICLE
Nevirapine
induced toxic epidermal necrolysis and non-Hodgkin lymphoma in a Human
Immunodeficiency Virus positive patient.
Indian Dermatol Online J .
2014 Apr;5(2):179-81
Paper
Rash and hepatitis within days of starting a new antiretroviral
regimen: Nevirapine hypersensitivity, secondary syphilis or both?
Saxon CJ, Helbert MR, Komolafe AJ, Higgins SP.
Int J STD AIDS . 2013 Aug 8.
Abstract
I dentification
of ‘Danger’ Signals in Nevirapine-Induced Skin Rash.
Zhang X, Sharma AM, Uetrecht J.
. 2013 Aug 15
Abstract
FULL-TEXT PDF ARTICLE
Association of Nevirapine Levels with Rash or Hepatotoxicity Among
HIV-Infected Thai Women.
Ratanasuwan W, Jariyasethpong T, Anekthananon T,
et al
Open AIDS J .
2012;6:266-73.
Paper
FULL-TEXT
DOCUMENT
HLA involvement in nevirapine-induced dermatological reaction in
antiretroviral-treated HIV-1 patients.
J Pharmacol Pharmacother .
2011 Apr;2(2):114-5.
Letter
Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse
events among
populations of African, Asian, and European descent.
Yuan J, Guo S, Hall D, et al . 2011 Apr
18.
Abstract
HLA-Cw*04 allele associated with nevirapine-induced rash in
HIV-infected Thai patients.
Likanonsakul S, Rattanatham T, Feangvad S,
et al
AIDS Res Ther . 2009 Oct 21;6(1):22.
Abstract
A Model and Risk Score for Predicting Nevirapine-Associated Rash among
HIV-infected Patients:
In Settings of Low CD4 Cell Counts and Resource Limitation. Kiertiburanakul S, Sungkanuparph
S, Malathum K
Open AIDS J . 2009 Jul
8;3:24-30.
Abstract
HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug
reactions in
HIV-infected Thai patients.
Chantarangsu S, Mushiroda T, Mahasirimongkol S, et al
. 2009 Dec
19
Abstract
Failure of a Short-Term Prednisone Regimen to Prevent Nevirapine-Associated Rash:
A Double-Blind Placebo-Controlled Trial: The GESIDA 09/99 Study.
Knobel H, Miro JM, Domingo P, et al .
J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):14-18.
Abstract
Ethics Main Page
Home Page
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader